© 2003 by Oxford University Press
© 2003 Oxford University Press
NEWS |
Central Clinical Trials Effort Draws Praise, Criticism
| The first 150 words of the full text of this article appear below. |
In 1997, a review group convened by the National Cancer Institute recommended that the NCIs clinical trials system be restructured to update its antiquated processes, take advantage of new technologies, and broaden patient access to clinical trials. One answer to that call was an ambitious 5-year, $50 million pilot project called the Cancer Trials Support Unit (CTSU).
There is anecdotal evidence that the CTSU is working. And many people in the cancer research community genuinely believe that the CTSU is a worthwhile effort, one that will ultimately pay off in fewer administrative burdens and more clinical options.
However, the program is entering its final year and has yet to be fully embraced by the cooperative groups, which historically have been charged with carrying out clinical trials. In addition, low accrual numbers are raising questions as to whether the system is making any difference at all.
Major Overhaul
The 1997 recommendations touched off
Low Accrual
Time Shall Tell
Finding Common Ground